Cingulate Common Stock vs Current Deferred Revenue Analysis

CING Stock

USD 0.70 0.02 2.78%

Cingulate financial indicator trend analysis is way more than just evaluating Cingulate prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cingulate is a good investment. Please check the relationship between Cingulate Common Stock and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.

Common Stock vs Current Deferred Revenue

Common Stock vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cingulate Common Stock account and Current Deferred Revenue. At this time, the significance of the direction appears to have very week relationship.

The correlation between Cingulate's Common Stock and Current Deferred Revenue is 0.24. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Cingulate, assuming nothing else is changed. The correlation between historical values of Cingulate's Common Stock and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Cingulate are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Common Stock i.e., Cingulate's Common Stock and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.24

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Common Stock

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Cingulate's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cingulate current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.The current Selling General Administrative is estimated to decrease to 6,431. The current Issuance Of Capital Stock is estimated to decrease to about 5.3 M

	2021	2022	2023	2024 (projected)
Total Operating Expenses	20.7M	17.5M	22.2M	17.4M
Cost Of Revenue	808.4K	622.0K	582.9K	667.6K

Total Operating Expenses Cost Of Revenue

Cingulate fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock
Total Assets		-0.16	-0.07	-0.27	0.03	0.4	0.09	-0.05	-0.97	-0.56	0.99	-0.01	0.11	0.99	0.99	-0.53	-0.4	-0.21	-0.36	0.8	0.25	-0.43	0.77	0.33	1.0	-0.4
Short Long Term Debt Total	-0.16		0.71	0.79	-0.95	0.6	-0.62	0.11	0.38	0.27	-0.16	-0.62	-0.6	-0.16	-0.3	-0.32	-0.46	-0.58	-0.58	0.43	0.08	0.78	0.13	0.49	-0.1	-0.46
Other Current Liab	-0.07	0.71		0.86	-0.5	0.83	-0.99	0.35	0.17	0.72	0.01	-0.98	-0.98	0.01	-0.19	-0.55	-0.76	-0.94	-0.9	0.21	0.73	0.8	0.53	0.87	0.03	-0.72
Total Current Liabilities	-0.27	0.79	0.86		-0.57	0.76	-0.86	0.24	0.39	0.65	-0.22	-0.82	-0.85	-0.22	-0.39	-0.26	-0.57	-0.75	-0.69	0.09	0.47	0.98	0.27	0.74	-0.2	-0.51
Total Stockholder Equity	0.03	-0.95	-0.5	-0.57		-0.47	0.38	-0.03	-0.28	0.02	0.07	0.41	0.36	0.07	0.17	0.3	0.35	0.4	0.44	-0.57	0.14	-0.56	-0.06	-0.3	0.0	0.34
Net Tangible Assets	0.4	0.6	0.83	0.76	-0.47		-0.82	0.3	-0.29	0.31	0.46	-0.85	-0.8	0.46	0.28	-0.69	-0.88	-0.92	-0.95	0.58	0.72	0.63	0.82	0.97	0.48	-0.76
Property Plant And Equipment Net	0.09	-0.62	-0.99	-0.86	0.38	-0.82		-0.41	-0.16	-0.76	0.0	0.99	0.99	0.0	0.2	0.55	0.78	0.94	0.89	-0.12	-0.8	-0.79	-0.54	-0.89	-0.01	0.68
Current Deferred Revenue	-0.05	0.11	0.35	0.24	-0.03	0.3	-0.41		0.03	0.16	0.01	-0.48	-0.33	0.01	-0.04	-0.71	-0.68	-0.51	-0.4	-0.05	0.51	0.16	0.2	0.42	0.0	0.24
Net Debt	-0.97	0.38	0.17	0.39	-0.28	-0.29	-0.16	0.03		0.52	-0.97	-0.08	-0.17	-0.97	-0.99	0.45	0.32	0.12	0.25	-0.63	-0.3	0.54	-0.74	-0.26	-0.96	0.3
Accounts Payable	-0.56	0.27	0.72	0.65	0.02	0.31	-0.76	0.16	0.52		-0.47	-0.68	-0.8	-0.47	-0.61	0.01	-0.24	-0.53	-0.41	-0.5	0.59	0.68	0.06	0.46	-0.49	-0.4
Cash	0.99	-0.16	0.01	-0.22	0.07	0.46	0.0	0.01	-0.97	-0.47		-0.09	0.02	1.0	0.98	-0.58	-0.47	-0.29	-0.43	0.77	0.36	-0.38	0.83	0.41	1.0	-0.45
Non Current Assets Total	-0.01	-0.62	-0.98	-0.82	0.41	-0.85	0.99	-0.48	-0.08	-0.68	-0.09		0.98	-0.09	0.11	0.66	0.85	0.98	0.93	-0.21	-0.82	-0.74	-0.6	-0.91	-0.1	0.68
Non Currrent Assets Other	0.11	-0.6	-0.98	-0.85	0.36	-0.8	0.99	-0.33	-0.17	-0.8	0.02	0.98		0.02	0.22	0.48	0.72	0.92	0.87	-0.09	-0.79	-0.8	-0.53	-0.87	0.01	0.72
Cash And Short Term Investments	0.99	-0.16	0.01	-0.22	0.07	0.46	0.0	0.01	-0.97	-0.47	1.0	-0.09	0.02		0.98	-0.58	-0.47	-0.29	-0.43	0.77	0.36	-0.38	0.83	0.4	1.0	-0.45
Net Receivables	0.99	-0.3	-0.19	-0.39	0.17	0.28	0.2	-0.04	-0.99	-0.61	0.98	0.11	0.22	0.98		-0.47	-0.31	-0.1	-0.24	0.72	0.2	-0.54	0.71	0.22	0.97	-0.28
Common Stock Shares Outstanding	-0.53	-0.32	-0.55	-0.26	0.3	-0.69	0.55	-0.71	0.45	0.01	-0.58	0.66	0.48	-0.58	-0.47		0.93	0.78	0.79	-0.59	-0.65	-0.1	-0.73	-0.71	-0.59	0.36
Short Term Investments	-0.4	-0.46	-0.76	-0.57	0.35	-0.88	0.78	-0.68	0.32	-0.24	-0.47	0.85	0.72	-0.47	-0.31	0.93		0.93	0.93	-0.5	-0.8	-0.42	-0.78	-0.91	-0.48	0.51
Non Current Liabilities Total	-0.21	-0.58	-0.94	-0.75	0.4	-0.92	0.94	-0.51	0.12	-0.53	-0.29	0.98	0.92	-0.29	-0.1	0.78	0.93		0.98	-0.38	-0.85	-0.63	-0.74	-0.96	-0.3	0.7
Capital Lease Obligations	-0.36	-0.58	-0.9	-0.69	0.44	-0.95	0.89	-0.4	0.25	-0.41	-0.43	0.93	0.87	-0.43	-0.24	0.79	0.93	0.98		-0.53	-0.81	-0.56	-0.82	-0.96	-0.45	0.78
Other Current Assets	0.8	0.43	0.21	0.09	-0.57	0.58	-0.12	-0.05	-0.63	-0.5	0.77	-0.21	-0.09	0.77	0.72	-0.59	-0.5	-0.38	-0.53		0.08	-0.03	0.65	0.42	0.82	-0.51
Other Stockholder Equity	0.25	0.08	0.73	0.47	0.14	0.72	-0.8	0.51	-0.3	0.59	0.36	-0.82	-0.79	0.36	0.2	-0.65	-0.8	-0.85	-0.81	0.08		0.35	0.77	0.86	0.33	-0.58
Total Liab	-0.43	0.78	0.8	0.98	-0.56	0.63	-0.79	0.16	0.54	0.68	-0.38	-0.74	-0.8	-0.38	-0.54	-0.1	-0.42	-0.63	-0.56	-0.03	0.35		0.1	0.62	-0.35	-0.43
Net Invested Capital	0.77	0.13	0.53	0.27	-0.06	0.82	-0.54	0.2	-0.74	0.06	0.83	-0.6	-0.53	0.83	0.71	-0.73	-0.78	-0.74	-0.82	0.65	0.77	0.1		0.82	0.83	-0.75
Property Plant And Equipment Gross	0.33	0.49	0.87	0.74	-0.3	0.97	-0.89	0.42	-0.26	0.46	0.41	-0.91	-0.87	0.4	0.22	-0.71	-0.91	-0.96	-0.96	0.42	0.86	0.62	0.82		0.41	-0.73
Total Current Assets	1.0	-0.1	0.03	-0.2	0.0	0.48	-0.01	0.0	-0.96	-0.49	1.0	-0.1	0.01	1.0	0.97	-0.59	-0.48	-0.3	-0.45	0.82	0.33	-0.35	0.83	0.41		-0.46
Capital Stock	-0.4	-0.46	-0.72	-0.51	0.34	-0.76	0.68	0.24	0.3	-0.4	-0.45	0.68	0.72	-0.45	-0.28	0.36	0.51	0.7	0.78	-0.51	-0.58	-0.43	-0.75	-0.73	-0.46

Click cells to compare fundamentals

Cingulate Account Relationship Matchups

Currently Active Assets on Macroaxis

V	Visa Class A
BAC	Bank of America
GM	General Motors
GOOG	Alphabet Inc Class C
CRM	Salesforce

When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:

How To Invest In Cingulate

Details

Is Cingulate Stock a good investment?

Details

What is Cingulate's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.

You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Cingulate Stock analysis

When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.

	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	CEOs Directory Screen CEOs from public companies around the world
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years

Is Cingulate's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(19.52)

Return On Assets

(1.91)

Return On Equity

(5.13)

The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cingulate Common Stock vs Current Deferred Revenue Analysis

Common Stock vs Current Deferred Revenue

Common Stock vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Common Stock

Current Deferred Revenue

Cingulate fundamental ratios Correlations

Cingulate Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Currently Active Assets on Macroaxis

Complementary Tools for Cingulate Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets

Net Receivables	- 0.99	Net Debt
Property Plant And Equipment Net	- 0.99	Other Current Liab
Non Currrent Assets Other	- 0.98	Other Current Liab
Non Current Assets Total	- 0.98	Other Current Liab
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt